Page last updated: 2024-10-28
ibudilast and Diabetic Neuropathies
ibudilast has been researched along with Diabetic Neuropathies in 1 studies
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Ibudilast was generally well tolerated." | 2.73 | Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. ( Chang, E; Davidson, JB; Gibbons, JA; Gross, MI; He, L; Johnson, KW; Jones, D; Rolan, P; Sanftner, LM, 2008) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Rolan, P | 1 |
| Gibbons, JA | 1 |
| He, L | 1 |
| Chang, E | 1 |
| Jones, D | 1 |
| Gross, MI | 1 |
| Davidson, JB | 1 |
| Sanftner, LM | 1 |
| Johnson, KW | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Regeneration in Cervical Degenerative Myelopathy - a Multi-centre, Double-blind, Randomised, Placebo Controlled Trial Assessing the Efficacy of Ibudilast as an Adjuvant Treatment to Decompressive Surgery for Degenerative Cervical Myelopathy[NCT04631471] | Phase 3 | 400 participants (Anticipated) | Interventional | 2021-12-22 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for ibudilast and Diabetic Neuropathies